01—Abstract
Summary
Summary of the 8-K filed February 1, 2024. Cited figures are marked; the original filing is the authoritative source.
Tenet Healthcare Corporation (THC) reported on February 1, 2024 that it completed the sale of three South Carolina hospitals, affiliated physician practices, and other related operations (the "Divested Assets") to affiliates of Novant Health.
The base purchase price was $2.400 billiona in cash, subject to customary purchase price adjustments. The Company estimates the Transaction will result in a pretax gain of approximately $1.7 billion. It also estimates that, as a result of the pretax book gain, its income tax expense in 2024 would be favorably impacted by approximately $150 million due to a reduction in interest expense limitations.
The filing states that the gain is not expected to recur in income beyond 12 months from the Transaction. The filing includes unaudited pro forma condensed consolidated financial statements (Exhibit 99.1) showing the balance sheet as of September 30, 2023 and statements of operations for the year ended December 31, 2022 and the nine months ended September 30, 2023, as if the Transaction had occurred on those dates. Pro forma net gain on sale after income taxes is $1.099 billionb, and pro forma net operating revenues were reduced by $534 million for 2022 and $412 million for the nine months of 2023.
02—Key points
Key Highlights
- Completed sale of three South Carolina hospitals, affiliated physician practices, and related operations to affiliates of Novant Health
- Base purchase price of $2.400 billion in cash, subject to customary purchase price adjustments
- Estimated pretax gain of approximately $1.7 billion (pro forma pretax gain of $1.686 billion)
- Estimated 2024 income tax expense favorably impacted by approximately $150 million due to reduced interest expense limitations
- Pro forma net gain on sale of $1.099 billion after $587 million of income tax provision
- Pro forma cash and cash equivalents rise to $3.449 billion from $1.054 billion historical as of September 30, 2023
- Pro forma 2022 net operating revenues of $18.640 billion versus $19.174 billion historical; nine-month 2023 pro forma revenues of $14.757 billion versus $15.169 billion historical
03—Questions
Frequently Asked Questions
What assets did Tenet Healthcare sell in this transaction?
Tenet sold three of its South Carolina hospitals, affiliated physician practices, and other related operations, collectively the Divested Assets, to affiliates of Novant Health.
How much cash did Tenet receive from the sale?
The base purchase price was $2.400 billion in cash, subject to customary purchase price adjustments. The pro forma statements net this against $5 million of transaction costs, for approximately $2,400 million net of $5 million in transaction costs.
What financial impact does Tenet expect from the transaction?
Tenet estimates a pretax gain of approximately $1.7 billion. It also expects its 2024 income tax expense to be favorably impacted by approximately $150 million due to a reduction in interest expense limitations resulting from the pretax book gain.
Will the gain from the sale recur in future results?
No. The filing states that the gain on sale is not expected to recur in income of the Company beyond 12 months from the Transaction.
How do the pro forma financial statements reflect the transaction?
The unaudited pro forma statements, filed as Exhibit 99.1, present the September 30, 2023 balance sheet as if the Transaction occurred on that date, and the 2022 and nine-month 2023 statements of operations as if it occurred on January 1, 2022. They should be read with Tenet's 2022 Form 10-K and its Q3 2023 Form 10-Q.
04—Continue